Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Increase in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 770 shares, a growth of 116.3% from the April 15th total of 356 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 5,950 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

A number of hedge funds and other institutional investors have recently bought and sold shares of FMED. Virtu Financial LLC purchased a new stake in shares of Fidelity Disruptive Medicine ETF during the fourth quarter worth $228,000. Jane Street Group LLC grew its position in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after purchasing an additional 44,630 shares in the last quarter. Vise Technologies Inc. purchased a new position in shares of Fidelity Disruptive Medicine ETF in the fourth quarter valued at $234,000. Glass Jacobson Investment Advisors llc raised its stake in shares of Fidelity Disruptive Medicine ETF by 44.0% during the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after purchasing an additional 385 shares during the period. Finally, BXM Wealth LLC bought a new stake in shares of Fidelity Disruptive Medicine ETF during the 4th quarter valued at $243,000.

Fidelity Disruptive Medicine ETF Stock Down 2.6%

NASDAQ FMED opened at $24.06 on Friday. The company’s 50 day moving average is $24.86 and its 200-day moving average is $26.27. Fidelity Disruptive Medicine ETF has a 12-month low of $22.80 and a 12-month high of $29.07. The firm has a market cap of $55.34 million, a P/E ratio of 41.33 and a beta of 0.84.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.